Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee repeals insulin-price bill after sponsor cites $8 million state cost; emergency clause retained
Summary
The Senate Public Health, Welfare and Labor Committee voted to repeal Senate Bill 7 after its sponsor said the measure, while intended to lower insulin prices, would cost the state about $8 million; the sponsor said the emergency clause remains and he plans to return with a new approach in 2023.
The Senate Public Health, Welfare and Labor Committee voted to repeal Senate Bill 7 after the bill's sponsor said the proposal, although aimed at lowering the "bottom line price" of insulin, would have imposed substantial costs on the state.
Senator Sullivan, who opened by thanking the chair and noting the bill was on the governor's call, told the committee he intended to "repeal my bill" rather than pursue it in its current form. "It was gonna take the bottom line…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
